The Allstate Corporation $ALL Stock: Orange Investment Advisors Inc. Increases Holdings

Orange Investment Advisors Inc. boosted its holdings in shares of The Allstate Corporation (NYSE:ALL) by 39.8% in the 3rd quarter, Holdings Channel.com reports. The fund owned 17,532 shares of the insurance provider’s stock after buying an additional 4,991 shares during the quarter. Orange Investment Advisors Inc.’s holdings in Allstate were worth $3,890,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Gables Capital Management Inc. purchased a new stake in Allstate in the second quarter valued at approximately $26,000. Allied Private Wealth LLC acquired a new stake in Allstate during the 2nd quarter worth approximately $29,000. Kelleher Financial Advisors purchased a new position in Allstate in the 2nd quarter valued at approximately $28,000. Transamerica Financial Advisors LLC purchased a new position in Allstate in the 2nd quarter valued at approximately $32,000. Finally, Highland Investment Advisors LLC acquired a new position in shares of Allstate in the second quarter worth $31,000. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate News Roundup

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Allstate prevailed in a Texas coverage dispute involving a vacant property. The ruling supports the insurer’s ability to enforce policy vacancy provisions, potentially limiting claims costs and reinforcing underwriting discipline. Vacant clause can void cover: US court backs Allstate in Texas case
• Positive Sentiment: Allstate retained $9,000 in a subrogation-related dispute after a court placed the premature filing cost on the opposing liability carrier. The financial impact is small, but the decision may support Allstate’s claims-handling position. Allstate keeps $9,000 as premature subrogation cost falls on liability carrier
• Positive Sentiment: Bank of America raised its price target on Allstate to $340 from $336, signaling continued confidence in the insurer’s earnings outlook and valuation. BofA raises target from $336 to $340
• Positive Sentiment: A valuation-focused analysis said Allstate still appears inexpensive despite a 131% advance, potentially attracting investors who expect further benefits from strong insurance pricing and improved profitability. Allstate stock still looks cheap after its 131% run
• Neutral Sentiment: Allstate shares gained 3.76% in the referenced session, although KBW maintained its Sell rating, highlighting a disconnect between short-term trading momentum and analyst conviction. KBW keeps Sell rating
• Neutral Sentiment: UBS reiterated its Hold rating, offering no new catalyst but indicating the firm sees limited justification for changing its current view. UBS keeps Hold rating
• Negative Sentiment: Analysts expect Allstate’s third-quarter earnings per share to decline by double digits year over year, creating concern ahead of the company’s November earnings release. What to expect from Allstate’s next quarterly earnings report
• Negative Sentiment: KBW’s continued Sell rating remains a notable overhang, suggesting the firm believes Allstate’s strong rally has outpaced its fundamental value. KBW keeps Sell rating
• Negative Sentiment: The price target for Allstate’s preferred stock was reduced 12.29% to $19.21, signaling weaker expectations for that security, although it does not directly change the valuation of the common shares. Allstate preferred stock price target decreased

Wall Street Analysts Forecast Growth

ALL has been the topic of a number of recent research reports. Piper Sandler reaffirmed an “overweight” rating on shares of Allstate in a research report on Monday, September 28th. BMO Capital Markets lifted their target price on Allstate from $250.00 to $284.00 and gave the company an “outperform” rating in a report on Thursday, August 13th. TD Cowen boosted their target price on Allstate from $231.00 to $260.00 and gave the stock a “hold” rating in a research note on Wednesday, September 23rd. Roth Capital set a $300.00 target price on Allstate in a research note on Thursday, August 6th. Finally, JPMorgan Chase & Co. upped their price target on Allstate from $282.00 to $292.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $270.19.

Insider Buying and Selling at Allstate

In related news, COO Mario Rizzo sold 56,225 shares of the stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $264.48, for a total value of $14,870,388.00. Following the transaction, the chief operating officer directly owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This trade represents a 40.61% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider John Dugenske sold 32,996 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the completion of the transaction, the insider directly owned 13,054 shares in the company, valued at $3,515,833.82. This trade represents a 71.65% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.55% of the company’s stock.

Allstate Stock Performance

Shares of ALL opened at $253.24 on Monday. The company has a market capitalization of $64.03 billion, a price-to-earnings ratio of 5.06, a price-to-earnings-growth ratio of 0.56 and a beta of 0.13. The Allstate Corporation has a 52-week low of $188.08 and a 52-week high of $277.22. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24. The stock has a 50 day moving average price of $245.78 and a 200 day moving average price of $236.83.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, August 5th. The insurance provider reported $8.99 earnings per share for the quarter, topping analysts’ consensus estimates of $6.06 by $2.93. The company had revenue of $18.60 billion for the quarter, compared to analysts’ expectations of $15.46 billion. Allstate had a net margin of 18.97% and a return on equity of 41.64%. The firm’s revenue for the quarter was up 11.8% on a year-over-year basis. During the same quarter last year, the company earned $5.94 earnings per share. Research analysts predict that The Allstate Corporation will post 36.21 EPS for the current fiscal year.

Allstate Company Profile

Allstate Corp. (NYSE: ALL) is an insurance company that provides protection products and related services primarily in the United States. Its offerings include automobile, homeowners, renters, condominium, motorcycle and other personal property and casualty insurance, distributed through agents, brokers, direct channels and digital platforms.

The company also provides roadside assistance, identity-protection services and protection plans for consumer products. Through its acquisition of National General, Allstate expanded its presence in independent-agent distribution and specialty personal insurance.